Cargando…

Detection of ras Gene Mutations in Perioperative Peripheral Blood with Pancreatic Adenocarcinoma

Surgeons wish to know of any correlation between an operation and the incidence of metastasis. In perioperative periods, pancreatic cancer cells were identified by detecting mutant K‐ras gene by two‐step PCR and RFLP analysis in blood samples taken from peripheral blood. In no case was K‐ras point m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nomoto, Shuji, Nakao, Akimasa, Kasai, Yasushi, Harada, Akio, Nonami, Toshiaki, Takagi, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1996
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921177/ https://www.ncbi.nlm.nih.gov/pubmed/8797884 http://dx.doi.org/10.1111/j.1349-7006.1996.tb02102.x

Ejemplares similares

Detection of Hepatic Micrometastasis in Pancreatic Adenocarcinoma Patients by Two‐stage Polymerase Chain Reaction/Restriction Fragment Length Polymorphism Analysis
por: Inoue, Soichiro, et al.
Publicado: (1995)

Characterization of High‐grade Neuroendocrine Tumors of the Lung in Relation to menin Mutations
por: Haruki, Nobuhiro, et al.
Publicado: (2000)

Dissected peripancreatic tissue margin is a critical prognostic factor and is associated with a K-ras gene mutation in pancreatic ductal adenocarcinoma
por: Nishizawa, Nobuyuki, et al.
Publicado: (2019)

Perioperative Management of Factor V Leiden and Pancreatic Adenocarcinoma
por: O'Malley, Thomas J., et al.
Publicado: (2017)

Colorectal Cancers with both p16 and p14 Methylation Show Invasive Characteristics
por: Hibi, Kenji, et al.
Publicado: (2002)

Mesenteric approach during pancreaticoduodenectomy for pancreatic ductal adenocarcinoma
por: Hirono, Seiko, et al.
Publicado: (2017)

c‐Ki‐rasPoint Mutations in Ductectatic‐type Mucinous Cystic Neoplasms of the Pancreas
por: Yanagisawa, Akio, et al.
Publicado: (1991)

Selection and Outcome of Portal Vein Resection in Pancreatic Cancer
por: Nakao, Akimasa
Publicado: (2010)

Cytotoxicity of Simvastatin to Pancreatic Adenocarcinoma Cells Containing Mutant ras Gene
por: Ura, Hitoshi, et al.
Publicado: (1994)

Multiple K‐ras Mutations in Hyperplasia and Carcinoma in Cases of Human Pancreatic Carcinoma
por: Matsubayashi, Hiroyuki, et al.
Publicado: (1999)

K‐ras and p53 Alterations in Genomic DNA and Transcripts of Human Pancreatic Adenocarcinoma Cell Lines
por: Suwa, Hirofumi, et al.
Publicado: (1994)

Infrequent ras Mutation in Human Stomach Cancers
por: Koshiba, Masahiro, et al.
Publicado: (1993)

Frequency and spectrum of c-Ki-ras mutations in human sporadic colon carcinoma, carcinomas arising in ulcerative colitis, and pancreatic adenocarcinoma.
por: Burmer, G C, et al.
Publicado: (1991)

Clinicopathological and prognostic features of surgically resected pathological stage I lung adenocarcinoma harboring epidermal growth factor receptor and K‐ras mutation
por: Kaseda, Kaoru, et al.
Publicado: (2017)

RAS Mutations and Oncogenesis: Not all RAS Mutations are Created Equally
por: Miller, Mark Steven, et al.
Publicado: (2012)

Inverse Probability of Treatment Weighting Analysis of Upfront Surgery Versus Neoadjuvant Chemoradiotherapy Followed by Surgery for Pancreatic Adenocarcinoma with Arterial Abutment
por: Fujii, Tsutomu, et al.
Publicado: (2015)

κB-Ras and Ral GTPases regulate acinar to ductal metaplasia during pancreatic adenocarcinoma development and pancreatitis
por: Beel, Stephanie, et al.
Publicado: (2020)

Identification of K‐ras Oncogene Mutations in the Pure Pancreatic Juice of Patients with Ductal Pancreatic Cancers
por: Watanabe, Hiroyuki, et al.
Publicado: (1993)

Detection of K‐ras Point Mutations at Codon 12 in Pancreatic Juice for the Diagnosis of Pancreatic Cancer by Hybridization Protection Assay: A Simple Method for the Determination of the Types of Point Mutations
por: Watanabe, Hiroyuki, et al.
Publicado: (1996)

Targeting the prohibitin scaffold-CRAF kinase interaction in RAS-ERK-driven pancreatic ductal adenocarcinoma
por: Luan, Zhou, et al.
Publicado: (2014)

GOLPH2, a gene downstream of ras signaling, promotes the progression of pancreatic ductal adenocarcinoma
por: Duan, Juan, et al.
Publicado: (2018)

Evaluation of K-ras and p53 expression in pancreatic adenocarcinoma using the cancer genome atlas
por: Lu, Liming, et al.
Publicado: (2017)

Vav1 and mutant K-Ras synergize in the early development of pancreatic ductal adenocarcinoma in mice
por: Salaymeh, Yaser, et al.
Publicado: (2020)

Interaction between smoking and asbestos in human lung adenocarcinoma: role of K-ras mutations.
por: Vainio, H, et al.
Publicado: (1993)

EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition
por: Rotella, Virginia, et al.
Publicado: (2014)

Point Mutation of c‐Ki‐ras Oncogene in Gastric Adenoma and Adenocarcinoma with Tubular Differentiation
por: Kihana, Toshimasa, et al.
Publicado: (1991)

Sensitization of Human Pancreatic Cancer Cells Harboring Mutated K-ras to Apoptosis
por: Shen, Ling, et al.
Publicado: (2012)

Prognostic significance of K-ras mutations in pancreatic cancer: a meta-analysis
por: Tao, Lian-yuan, et al.
Publicado: (2016)

Absence of ras Mutations and Low Incidence of p53 Mutations in Renal Cell Carcinomas Induced by Ferric Nitrilotriacetate
por: Akiyama, Takashi, et al.
Publicado: (1995)

Crosstalk Between Peripheral Innervation and Pancreatic Ductal Adenocarcinoma
por: Ni, Bo, et al.
Publicado: (2023)

Frequent Glycine‐to‐Aspartic Acid Mutations at Codon 12 of c‐Ki‐ras Gene in Human Pancreatic Cancer in Japanese
por: Nagata, Yasuhiko, et al.
Publicado: (1990)

K-RAS Mutant Gene Found in Pancreatic Juice Activated Chromatin From Peri-ampullary Adenocarcinomas
por: Reza, Joseph, et al.
Publicado: (2019)

Hyperactivation of ERK by multiple mechanisms is toxic to RTK-RAS mutation-driven lung adenocarcinoma cells
por: Unni, Arun M, et al.
Publicado: (2018)

Beyond the Genomic Mutation: Rethinking the Molecular Biomarkers of K-RAS Dependency in Pancreatic Cancers
por: Mottini, Carla, et al.
Publicado: (2020)

Cytoplasmic expression of LGR5 in pancreatic adenocarcinoma
por: Mizuno, Nobumasa, et al.
Publicado: (2013)

Japanese Society of Medical Oncology Clinical Guidelines: RAS (KRAS/NRAS) mutation testing in colorectal cancer patients11
por: Taniguchi, Hiroya, et al.
Publicado: (2015)

Influence of Body Mass Index and Albumin on Perioperative Morbidity and Clinical Outcomes in Resected Pancreatic Adenocarcinoma
por: Hendifar, Andrew, et al.
Publicado: (2016)

Effect of Perioperative CEA and CA24-2 on Prognosis of Early Resectable Pancreatic Ductal Adenocarcinoma
por: Li, Xiaojie, et al.
Publicado: (2020)

Perioperative and oncological outcomes following minimally invasive versus open pancreaticoduodenectomy for pancreatic duct adenocarcinoma
por: Sun, Rui, et al.
Publicado: (2020)

Perioperative oncolytic virotherapy to counteract surgery-induced immunosuppression and improve outcomes in pancreatic ductal adenocarcinoma
por: Mansouri, Sarah, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l0kpoju74b2vh2mnka8r46m5o9